[3] Yang LM et al., Abstract 5510: Preclinical study of allogeneic CD19-CARDNT cells as an off-the-shelf immunotherapy drug for NHL, Cancer Res(2022) 82 (12_Supplement): 5510, https://doi.org/10.1158/1538-...
恶性淋巴瘤是原发于淋巴结和结外淋巴组织的恶性肿瘤,占我国所有恶性肿瘤的3%-4%。淋巴瘤依淋巴结是否出现恶性Reed-Sternberg细胞 (RS cells) 区分为霍奇金淋巴瘤 (Hodgkin Lymphoma, HL) 与非霍奇金淋巴瘤 (Non-Hodgkin Lymphoma, NHL) 。依临床进展情况NHL大致分为惰性淋巴瘤和侵袭性淋巴瘤,惰性淋巴瘤进展缓慢...
The killing of CD19-CAR-DNT cells on Raji-luciferase cells was 77.92% (n=6) at the effector to target ratio of 4:1. Elevated IFN-纬 release from CD19-CAR-DNT cells after overnight co-culture with Raji cells was observed. The antitumor efficacy was evaluated in the xenografted NHL ...